ADIL
Adial Pharmaceuticals
ADIL
ADIL
22 hedge funds and large institutions have $6.29M invested in Adial Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
4% less funds holding
Funds holding: 23 → 22 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Holders
22
Holding in Top 10
–
Calls
$154K
Puts
$68K
Top Buyers
| 1 | +$3.65M | |
| 2 | +$70K | |
| 3 | +$40K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$14.3K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$11.8K |
Top Sellers
| 1 | -$56K | |
| 2 | -$53K | |
| 3 | -$41K | |
| 4 |
Charles Schwab
San Francisco,
California
|
-$32K |
| 5 |
BlackRock
New York
|
-$3.42K |